Ipca Laboratories | Sustainability Performance
Develops, manufactures, and markets pharmaceutical products across therapeutic areas such as cardiology, dermatology, and pain management. Its portfolio includes branded formulations, generics, and active pharmaceutical ingredients. The company distributes its products globally to healthcare providers and patients.
1949
India
10,001+ employees
Pharmaceuticals
$1B - 10B in revenue
$25M - 100M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#8580
Overallⓘ#247
in Indiaⓘ#205
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Controversy level
- IPCA Laboratories Limited, Indian pharma, has faced sustained US FDA enforcement actions including the historic 2014 USD 47 million Import Alert affecting multiple IPCA production facilities, plus periodic class actions over alleged inadequate disclosure of US generic pharma customer concentration affecting Indian institutional shareholders.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
7-10
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.